In order to validate the influence of HTR2A/2B on the invasion ability of breast cancer cells, CD8+ T cells pre-treated with HTR2A or HTR2B inhibitors were co-cultured with 4T1 cells and subjected to transwell assay. This evidence concerns the gene CD8A and breast carcinoma.